Articles from Konovo

Litmys, a life sciences commercial strategy consulting firm, specializing in the development of commercial readiness analytics, and Konovo, a technology-first healthcare intelligence company that accelerates access to customer insights across the healthcare ecosystem, today announced a partnership that will transform how life sciences companies make earlier, smarter, and more commercially informed R&D investment and clinical development decisions.

Konovo, a technology-first healthcare intelligence company, has appointed industry veteran Jessica Santos as Chief Compliance & Privacy Officer. With over 20 years of experience in healthcare compliance, AI governance, and data privacy, Jessica brings a wealth of market-specific expertise that will further Konovo’s mission to transform research through technology and deliver connected insights for healthcare organizations.

As Rare Disease Day 2026 approaches on February 28, a new Market Signals study by healthcare intelligence company Konovo, combined with data from its newly acquired Rare Patient Voice (RPV) unit, reveals a critical gap in care. Although 82% of patients with rare diseases face profound mental health challenges, nearly 40% of healthcare professionals (HCPs) in both the United States and the EU5 countries report that they do not conduct any mental health screening for these patients.

Konovo, a technology-first healthcare intelligence company, today announced it has acquired Rare Patient Voice (“RPV”), a patient recruitment company with over 200,000 registered patients and family caregivers across rare, chronic, and complex conditions. This strategic acquisition combines RPV's deep patient relationships and proven recruitment expertise with Konovo's intelligent platform, HCP access, and global scale, enabling healthcare researchers to access hard-to-reach patient populations with speed and reliability.

Konovo, a technology-first healthcare intelligence company, announced today that it has expanded its executive leadership team with the appointment of two healthcare technology industry veterans, Swathi Kulkarni, Managing Director, India and Tom Halliday, Chief Commercial Officer (CCO). With unprecedented demands upon life science organizations to do more with less, these appointments will accelerate the expansion of Konovo’s AI-native intelligent technology platform to meet the needs of all geographies – a platform that connects fragmented data and delivers deep insights to transform life science market research.

Konovo, a technology-first healthcare intelligence company, today announced Survey Studio, a new product that helps organizations design and script therapeutic-specific healthcare surveys in minutes—not weeks. Built on Konovo’s trusted life sciences intelligence and powered by agentic AI, Survey Studio streamlines the research design and programming workflow with precision, freeing teams to focus on data interpretation and strategic insights.

Konovo, a technology-first healthcare intelligence company, today announced the appointment of healthcare technology pioneer Jeremy Brody as a board advisor. With a 30-year track record of innovation in market research and health data technologies, Brody will help Konovo to accelerate the expansion of its AI-native intelligent platform.

Konovo, a technology-first healthcare intelligence company, named seasoned healthcare data industry veteran Tim Albury as its Chief Financial Officer (CFO.) His appointment will help Konovo to advance its AI-native intelligent platform for connecting fragmented data to develop insights and transform life science market research.

Konovo, a technology-first healthcare intelligence company, appointed real-world data (RWD) veteran Gadi Lachman to its Board of Directors. Lachman brings over 20 years of leadership in health technologies and a proven track record in developing scalable research platforms that will help accelerate Konovo’s initiatives to transform the life science market insights sector.

Konovo, a technology-first healthcare intelligence company, formally launched today with a new mission to simplify and enable research across the insights ecosystem of researchers, vendors and data sources. Building on a long history of success in research under three separate brands, Konovo applies technology to address the industry’s longstanding challenges: fragmentation, isolated learnings, and disengaged responders, all of which cause delays, reduce efficiencies, and affect quality. Fueled by new leadership, vision, and technology investment, Konovo is expanding the industry’s first AI-native, intelligent platform to streamline and accelerate deeper insights – rooted in its track record of award-winning AI innovations pioneered by InCrowd, SHG and GlocalMind.